Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Digital Health Meets AI -CSE: ALEN.U (click to learn more) New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Exagen Inc XGN

Healthcare Diagnostics & Research
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XGN)

Exagen Inc. Announces Select Preliminary 2025 Financial Results

GlobeNewswire January 11, 2026

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

GlobeNewswire November 11, 2025

Exagen Inc. Reports Strong Q3 2025 Results

GlobeNewswire November 4, 2025

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence

GlobeNewswire October 23, 2025

Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025

GlobeNewswire October 21, 2025

Exagen Inc. to Participate in Third Quarter Investor Conferences

GlobeNewswire August 6, 2025

Exagen Inc. Reports Strong Q2 2025 Results

GlobeNewswire July 29, 2025

Exagen Inc. Appoints Chas McKhann to Board of Directors

GlobeNewswire July 17, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

GlobeNewswire July 15, 2025
View More News ››

Opinion & Analysis (NDAQ:XGN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:XGN)

EXAGEN: ENABLING TIMELY DIAGNOSIS FOR LUPUS PATIENTS

$XGN  Excited to share an article about Exagen Inc. (NASDAQ: XGN), a provider of autoimmune testing solutions. ...
AviseAnalytics - February 20, 2024
View more Bullboard ››

dynaCERT Inc.

dynaCERT Inc.

dynaCERT Inc., together with its subsidiaries, engages in the design, engineering, manufacture, testing, and distribution of ...
View More »

Podcasts